BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22713758)

  • 1. Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model.
    Thompson SA; Burridge PW; Lipke EA; Shamblott M; Zambidis ET; Tung L
    J Mol Cell Cardiol; 2012 Jul; 53(1):15-23. PubMed ID: 22713758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo assessment of the electrophysiological integration and arrhythmogenic risk of myocardial cell transplantation strategies.
    Gepstein L; Ding C; Rahmutula D; Wilson EE; Yankelson L; Caspi O; Gepstein A; Huber I; Olgin JE
    Stem Cells; 2010 Dec; 28(12):2151-61. PubMed ID: 20960511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation.
    Kim C; Majdi M; Xia P; Wei KA; Talantova M; Spiering S; Nelson B; Mercola M; Chen HS
    Stem Cells Dev; 2010 Jun; 19(6):783-95. PubMed ID: 20001453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoceptor Responses in Human Embryonic Stem Cell-Derived Cardiomyocytes: a Special Focus on Electrophysiological Property.
    Jiang W; Hu X; Li F; Li G; Wang Y
    J Pharmacol Exp Ther; 2020 Jun; 373(3):429-437. PubMed ID: 32217769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes.
    Zhang D; Shadrin IY; Lam J; Xian HQ; Snodgrass HR; Bursac N
    Biomaterials; 2013 Jul; 34(23):5813-20. PubMed ID: 23642535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of aggregates of purified cardiomyocytes derived from human ESCs for functional engraftment after myocardial infarction.
    Moon SH; Kang SW; Park SJ; Bae D; Kim SJ; Lee HA; Kim KS; Hong KS; Kim JS; Do JT; Byun KH; Chung HM
    Biomaterials; 2013 May; 34(16):4013-4026. PubMed ID: 23465823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts.
    Shiba Y; Fernandes S; Zhu WZ; Filice D; Muskheli V; Kim J; Palpant NJ; Gantz J; Moyes KW; Reinecke H; Van Biber B; Dardas T; Mignone JL; Izawa A; Hanna R; Viswanathan M; Gold JD; Kotlikoff MI; Sarvazyan N; Kay MW; Murry CE; Laflamme MA
    Nature; 2012 Sep; 489(7415):322-5. PubMed ID: 22864415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of engineered anisotropy on the susceptibility of human pluripotent stem cell-derived ventricular cardiomyocytes to arrhythmias.
    Wang J; Chen A; Lieu DK; Karakikes I; Chen G; Keung W; Chan CW; Hajjar RJ; Costa KD; Khine M; Li RA
    Biomaterials; 2013 Nov; 34(35):8878-86. PubMed ID: 23942210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical coupling between myofibroblasts and cardiomyocytes slows electric conduction in fibrotic cell monolayers.
    Thompson SA; Copeland CR; Reich DH; Tung L
    Circulation; 2011 May; 123(19):2083-93. PubMed ID: 21537003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological differences between transplanted and host tissue cause functional decoupling after in vitro transplantation of human embryonic stem cell-derived cardiomyocytes.
    Pillekamp F; Halbach M; Reppel M; Pfannkuche K; Nazzal R; Nguemo F; Matzkies M; Rubenchyk O; Hannes T; Khalil M; Bloch W; Sreeram N; Brockmeier K; Hescheler J
    Cell Physiol Biochem; 2009; 23(1-3):65-74. PubMed ID: 19255501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype.
    Pekkanen-Mattila M; Chapman H; Kerkelä E; Suuronen R; Skottman H; Koivisto AP; Aalto-Setälä K
    Exp Biol Med (Maywood); 2010 Apr; 235(4):522-30. PubMed ID: 20407085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical mapping of human embryonic stem cell-derived cardiomyocyte graft electrical activity in injured hearts.
    Filice D; Dhahri W; Solan JL; Lampe PD; Steele E; Milani N; Van Biber B; Zhu WZ; Valdman TS; Romagnuolo R; Otero-Cruz JD; Hauch KD; Kay MW; Sarvazyan N; Laflamme MA
    Stem Cell Res Ther; 2020 Sep; 11(1):417. PubMed ID: 32988411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetically engineered excitable cardiac myofibroblasts coupled to cardiomyocytes rescue normal propagation and reduce arrhythmia complexity in heterocellular monolayers.
    Hou L; Hu B; Jalife J
    PLoS One; 2013; 8(2):e55400. PubMed ID: 23393574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maturation of human embryonic stem cell-derived cardiomyocytes (hESC-CMs) in 3D collagen matrix: Effects of niche cell supplementation and mechanical stimulation.
    Zhang W; Kong CW; Tong MH; Chooi WH; Huang N; Li RA; Chan BP
    Acta Biomater; 2017 Feb; 49():204-217. PubMed ID: 27890729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro platform of allogeneic stem cell-derived cardiomyocyte transplantation for cardiac conduction defects.
    Yoshida A; Lee JK; Tomoyama S; Miwa K; Shirakawa K; Hamanaka S; Yamaguchi T; Nakauchi H; Miyagawa S; Sawa Y; Komuro I; Sakata Y
    Europace; 2018 Sep; 20(9):1553-1560. PubMed ID: 29554331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.
    Chong JJ; Yang X; Don CW; Minami E; Liu YW; Weyers JJ; Mahoney WM; Van Biber B; Cook SM; Palpant NJ; Gantz JA; Fugate JA; Muskheli V; Gough GM; Vogel KW; Astley CA; Hotchkiss CE; Baldessari A; Pabon L; Reinecke H; Gill EA; Nelson V; Kiem HP; Laflamme MA; Murry CE
    Nature; 2014 Jun; 510(7504):273-7. PubMed ID: 24776797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats.
    Fernandes S; Naumova AV; Zhu WZ; Laflamme MA; Gold J; Murry CE
    J Mol Cell Cardiol; 2010 Dec; 49(6):941-9. PubMed ID: 20854826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes.
    Weber N; Schwanke K; Greten S; Wendland M; Iorga B; Fischer M; Geers-Knörr C; Hegermann J; Wrede C; Fiedler J; Kempf H; Franke A; Piep B; Pfanne A; Thum T; Martin U; Brenner B; Zweigerdt R; Kraft T
    Basic Res Cardiol; 2016 Nov; 111(6):68. PubMed ID: 27743117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
    Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
    Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells.
    Blazeski A; Zhu R; Hunter DW; Weinberg SH; Boheler KR; Zambidis ET; Tung L
    Prog Biophys Mol Biol; 2012; 110(2-3):178-95. PubMed ID: 22958937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.